汉邦科技开启申购将上市：募资金额缩水5.5亿元，毅达资本已清仓

Core Viewpoint - Jiangsu Hanbang Technology Co., Ltd. (Hanbang Technology) is set to launch its IPO on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with a reduced fundraising target of approximately 430 million yuan, down from earlier projections of 980 million yuan and 598 million yuan [3][4][5]. Fundraising and Financials - The IPO price is set at 22.77 yuan per share, with a total issuance of 22 million shares, aiming to raise around 500 million yuan [3]. - The net fundraising amount has decreased by approximately 56%, equating to a reduction of 550 million yuan compared to earlier estimates [5]. - The company plans to allocate the raised funds primarily for production projects, including the annual production of 1,000 liquid chromatography separation equipment and the development of chromatography separation equipment [4][5]. Company Overview - Hanbang Technology, established in October 1998, focuses on chromatography technology, providing separation and purification equipment, consumables, and technical solutions primarily for the pharmaceutical and life sciences sectors [6]. - The company has a registered capital of 66 million yuan, with major shareholders including Zhang Dabin, WuXi AppTec, QK Venture Capital, and Sequoia [6]. Performance Metrics - Revenue projections for Hanbang Technology are approximately 482 million yuan for 2022, 619 million yuan for 2023, and 691 million yuan for 2024, with net profits of around 38.56 million yuan, 51.50 million yuan, and 79.34 million yuan respectively [7]. - The company has shown a compound annual growth rate (CAGR) of 38.99% in main business revenue from 2021 to 2023, but this rate is expected to slow to 19.78% from 2022 to 2024 [9]. - The total assets as of December 31, 2024, are projected to be approximately 1.32 billion yuan, with a debt-to-asset ratio of 44.17% [8].